Published in Medical Letter on the CDC and FDA, July 8th, 2007
The reference listed drug (Prilosec OTC(R), Omeprazole delayed-release tablets, 20 mg, AstraZeneca) is subject to a period of patent protection. Dexcel filed its NDA with a paragraph IV patent certification stating that the patents are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA